Barbra Pagarigan

1.9k total citations · 1 hit paper
8 papers, 719 citations indexed

About

Barbra Pagarigan is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Barbra Pagarigan has authored 8 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Oncology. Recurrent topics in Barbra Pagarigan's work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Ubiquitin and proteasome pathways (2 papers). Barbra Pagarigan is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Ubiquitin and proteasome pathways (2 papers). Barbra Pagarigan collaborates with scholars based in Switzerland, Germany and United States. Barbra Pagarigan's co-authors include Philip P. Chamberlain, Brian E. Cathers, Thomas O. Daniel, Mariko Riley, Gilles Carmel, S.L. Delker, Karen Miller, Laura G. Corral, Hideki Ando and Antonia Lopez‐Girona and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Barbra Pagarigan

7 papers receiving 699 citations

Hit Papers

Structure of the human Cereblon–DDB1–lenalidomide complex... 2014 2026 2018 2022 2014 100 200 300

Peers

Barbra Pagarigan
Comparison fields: 5 of 46
  • Molecular Biology 641
  • Hematology 321
  • Oncology 195
  • Immunology 62
  • Organic Chemistry 36
Teresa Paíno Spain
Mariko Riley United States
Mahan Abbasian United States
Yudao Shen United States
Eric S. Wang United States
Dhanusha A. Nalawansha United States
Emily Rychak Japan
Margherita Corbo United Kingdom
Huahang Sun United States
Brian W. Raden United States
Teresa Paíno Spain View profile →
Citations per field, relative to Barbra Pagarigan
Barbra Pagarigan · 1×
Citations per year, relative to Barbra Pagarigan
Barbra Pagarigan · 1×

Countries citing papers authored by Barbra Pagarigan

Since Specialization
Citations

This map shows the geographic impact of Barbra Pagarigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbra Pagarigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbra Pagarigan more than expected).

Fields of papers citing papers by Barbra Pagarigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbra Pagarigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbra Pagarigan. The network helps show where Barbra Pagarigan may publish in the future.

Co-authorship network of co-authors of Barbra Pagarigan

This figure shows the co-authorship network connecting the top 25 collaborators of Barbra Pagarigan. A scholar is included among the top collaborators of Barbra Pagarigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbra Pagarigan. Barbra Pagarigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Title Journal Authors Indexed citations
1 Application of Weighted Interaction-Fingerprints for Rationalizing Neosubstrate Potency and Selectivity of Cereblon-Based Molecular Glues Journal of Medicinal Chemistry Guilian Luchini, Shuang Liu et al. 0
2 Structure of the human marker of self 5-transmembrane receptor CD47 Nature Communications Gustavo Fenalti, Nicolas Villanueva et al. 35
3 Crystal structure of the SALL4–pomalidomide–cereblon–DDB1 complex Nature Structural & Molecular Biology Mary E. Matyskiela, Thomas Clayton et al. 65
4 Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy Journal of Medicinal Chemistry Jennifer R. Riggs, Dale Robinson et al. 17
5 A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos Journal of Medicinal Chemistry Mary E. Matyskiela, Weihong Zhang et al. 203
6 Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes PLoS ONE Philip P. Chamberlain, S.L. Delker et al. 11
7 Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs breakdown → Nature Structural & Molecular Biology Philip P. Chamberlain, Antonia Lopez‐Girona et al. 371
8 The 1.59 Å resolution crystal structure of TM0096, a flavin mononucleotide binding protein from Thermotoga maritima Proteins Structure Function and Bioinformatics K.S. Gajiwala, B.W. Noland et al. 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026